The Safety and Efficacy of XytriX (Umbilical Cord-Derived Mesenchymal Stem Cells) in the Treatment of Knee Osteoarthritis
Clinical trial NCT07487766 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07487766
- Sponsor
- TricelX Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2027-05-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.